 BEIJING, July 29, 2021 GLOBE NEWSWIRE -- Genetron Holdings Limited Genetron Health or the Company, NASDAQ: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will work with Guizhou Provinces Dafang County authorities to lead the Early Screening for Regional Liver Cancer Prevention and Containment Demonstration Project. Backed by the Central Committee of the Chinese Peasants and Workers Democratic Party and guided by Chinas National Cancer Center, this project is a collective effort that will be carried out by the Dafang County Health Bureau, the Peoples Hospital of Dafang, and Genetron Health. 